A broad-spectrum antibiotic called Revamox 625 IB Tablet efficiently treats a variety of bacterial infections by combining 500 mg of amoxicillin with 125 mg of potassium clavulanate. By blocking beta-lactamase enzymes, this synergistic combination increases amoxicillin's efficacy against bacterial strains that are resistant to it. Revamox 625 IB is frequently used to treat infections of the skin, soft tissues, ear, nose, throat, respiratory tract, and urinary tract.
